The development of a QALY measure for epilepsy: NEWQOL-6D. (Q48455264)

11 February 2018

title

The development of a QALY measure for epilepsy: NEWQOL-6D. (English)

1 reference

11 February 2018

quality-adjusted life year

main subject

1 reference

2

1 reference

11 February 2018

Dyfrig A. Hughes

6

1 reference

11 February 2018

Nicholas Latimer

7

1 reference

11 February 2018

John Edward Brazier

9

1 reference

11 February 2018

Brendan Mulhern

object named as

Brendan Mulhern

1

0 references

author name string

Ann Jacoby

3

1 reference

11 February 2018

Tony Marson

4

1 reference

11 February 2018

Dee Snape

5

1 reference

11 February 2018

Gus A Baker

8

1 reference

11 February 2018

publication date

12 April 2012

1 reference

11 February 2018

published in

Epilepsy Behavior

1 reference

11 February 2018

volume

24

1 reference

11 February 2018

issue

1

1 reference

11 February 2018

page(s)

36-43

1 reference

11 February 2018

EuroQol: the current state of play

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.025

The estimation of a preference-based measure of health from the SF-12.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.025

The estimation of a preference-based measure of health from the SF-36.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.025

Properties of the 15D and EQ-5D utility measures in a community sample of people with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.025

Quality of life pre and post epilepsy surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.025

Validity and responsiveness of generic preference-based HRQOL instruments in chronic epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.025

Do established health-related quality-of-life measures adequately capture the impact of chronic conditions on subjective well-being?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.025

Impact of the recall period on measuring health utilities for acute events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.025

Improving the Measurement of QALYs in Dementia: Developing Patient- and Carer-Reported Health State Classification Systems Using Rasch Analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.025

Deriving a preference-based measure for cancer using the EORTC QLQ-C30

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.025

Estimating preference-based single index measures for dementia using DEMQOL and DEMQOL-Proxy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.025

Estimating a Preference-Based Index for a 5-Dimensional Health State Classification for Asthma Derived from the Asthma Quality of Life Questionnaire

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.025

The first stage of developing preference-based measures: constructing a health-state classification using Rasch analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.025

Patient-based assessments of quality of life in newly diagnosed epilepsy patients: validation of the NEWQOL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.025

Felt versus enacted stigma: a concept revisited. Evidence from a study of people with epilepsy in remission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.025

The hospital anxiety and depression scale

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.025

Psychosocial outcomes of antiepileptic drug discontinuation. The Medical Research Council Antiepileptic Drug Withdrawal Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.025

The A-B neuropsychological assessment schedule (ABNAS): the relationship between patient-perceived drug related cognitive impairment and results of neuropsychological tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.025

The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.025

A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.025

Developing and testing methods for deriving preference-based measures of health from condition-specific measures (and other patient-based measures of outcome).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.025

The validity of the Hospital Anxiety and Depression Scale. An updated literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.025

Modeling valuations for EuroQol health states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.02.025

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YEBEH.2012.02.025

1 reference

11 February 2018

1 reference

11 February 2018